Severe left ventricular systolic dysfunction in a patient with a typical haemolytic–uraemic syndrome treated with rituximab—coincidence or cause?

A 26-year-old female with haemolytic–uraemic syndrome (HUS) refractory to daily plasma exchange was successfully treated with rituximab. Subsequent testing confirmed the presence of mutations in genes encoding complement factor I and CD46. On Day 32 she developed pulmonary oedema, and echocardiograp...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrie, Colin J., Weir, Robin A. P., Lindsay, Mitchell M., Padmanabhan, Neal, Douglas, Kenny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477969/
https://www.ncbi.nlm.nih.gov/pubmed/28657056
http://dx.doi.org/10.1093/ndtplus/sfq055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477969/
https://www.ncbi.nlm.nih.gov/pubmed/28657056
http://dx.doi.org/10.1093/ndtplus/sfq055

Ejemplares similares